Trial Profile
Calcineurin Inhibitor-Free Immunosuppression After Kidney Transplantation, Using Everolimus De Novo – Single Center Experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Basiliximab; Ciclosporin; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 20 Aug 2015 New trial record